The Medicare Privatization Scam

By Trudy Lieberman

This article appeared in the July 16, 2007 edition of The Nation.

June 27, 2007

In the next few weeks Congress will decide whether to cut $54 billion in overpayments to Medicare insurers, igniting a battle that may well determine whether the program survives. On one side are Medicare supporters, who want it to continue as a successful social insurance program. On the other is the insurance industry, which is spending millions and lobbying hard to put Medicare on a fast track to privatization, a goal long sought by fiscal conservatives and their allies in right-wing think tanks.

The seeds of the conflict were sown in 2003, when Congress passed the Medicare Modernization Act (MMA), which gives seniors a prescription drug benefit that is sold and administered by private insurers, not the government. This drug benefit, known as Part D, opened new markets for insurers, some of which have profited handsomely from the government's gift. The story of one of those companies, Humana, a forty-six-year-old carrier based in Louisville, Kentucky, shows what's at stake.

Before 2003 Humana, a regional company peddling health insurance, including HMOs, was hardly a household name. One of its policies had been a big money loser, and the company was struggling to dig its way out of a financial hole. Vice president Steve Brueckner called the MMA "an unprecedented opportunity to establish relationships," and his company made the most of it. Humana gained 4 million new policyholders and reported to stockholders in April that it had amassed "record breaking revenues." What's more, Humana has become a national brand poised to sell policies in the non-Medicare market, where people will increasingly be forced to buy their own health coverage, especially if an "individual mandate" becomes a solution for the country's healthcare woes. "Part D transformed the company," says Bridget Maehr, an analyst for A.M. Best, an insurance rating service.

Subscriber Login

4 ISSUES FREE

Subscribe Now!

The only way to read this article and the full contents of each week's issue of The Nation online is by subscribing to the magazine. Subscribe now and read this article -- and every article published since for the past five years -- right now.

There's no obligation -- try The Nation for four weeks free.

.

About Trudy Lieberman

Trudy Lieberman, a regular Nation contributor on healthcare, is director of the health and medicine reporting program at the CUNY Graduate School of Journalism. She is also reporting on media coverage of healthcare for the Campaign Desk of the Columbia Journalism Review (CJR.org). more...
Most Read

Issues »

Most Emailed

Issues »

Popular Topics

Blogs

» The Notion

Hillary's Big Ethics Problem: Bill | The story of Bill Clinton and his Kazakh uranium deal suggests that some guidelines are needed.
Jon Wiener

» State of Change

It's 3 a.m., Hillary's on the Phone | It looks like Clinton will be the Secretary of State.
John Nichols

» Capitolism

Left Out | Would it kill Obama to have an actual progressive or two in his cabinet?
Christopher Hayes

» The Beat

Key Committee Pick Signals Obama-Pelosi Direction | Waxman gets Commerce chair, amid signs of focus on healthcare, environment, consumer protection.
John Nichols

» The Dreyfuss Report

That Iranian "Bomb"? Relax. | Obama has lots and lots of time to deal with this problem carefully and rationally.
Robert Dreyfuss

» Passing Through

Should GM Survive? A Wall Street Analyst's View | Maybe they should just let it die.
Jane Hamsher

» Act Now!

Take the Joe Lieberman Pledge | In America, it's never too early to start preparing for the next election.
Peter Rothberg

» Editor's Cut

Smart Defense | Rep. Barney Frank is leading the charge to end the Pentagon's weapons spending spree. Is anybody listening?
Katrina vanden Heuvel

» And Another Thing

Election Updates --Good News and Not | Details on some ongoing stories
Katha Pollitt